People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Anumana, Inc. | — | Biotechnology | Series B | $32.0M | $464.8M | 2022 |
| nference, inc. | — | Biotechnology | Series A | $12.3M | $32.6M | 2020 |
Murali Aravamudan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Murali Aravamudan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harris Fishman | 2 | 4 |
| David Goel | 2 | 3 |
| Alan Colowick | 1 | 7 |
| Tim Barrows | 1 | 5 |
| Andrew Danielsen | 1 | 3 |
| Kyle Bettigole | 1 | 2 |
| Thomas McNaughton | 1 | 2 |
| John Halamka | 1 | 1 |
| Ajit Rajasekharan | 1 | 1 |
| Agustin Marquez | 1 | 1 |
| Cheranjit Rihal | 1 | 1 |
| Venkataramanan Soundararajan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.